368 related articles for article (PubMed ID: 26013381)
1. Activating MET kinase rearrangements in melanoma and Spitz tumours.
Yeh I; Botton T; Talevich E; Shain AH; Sparatta AJ; de la Fouchardiere A; Mully TW; North JP; Garrido MC; Gagnon A; Vemula SS; McCalmont TH; LeBoit PE; Bastian BC
Nat Commun; 2015 May; 6():7174. PubMed ID: 26013381
[TBL] [Abstract][Full Text] [Related]
2. NTRK3 kinase fusions in Spitz tumours.
Yeh I; Tee MK; Botton T; Shain AH; Sparatta AJ; Gagnon A; Vemula SS; Garrido MC; Nakamaru K; Isoyama T; McCalmont TH; LeBoit PE; Bastian BC
J Pathol; 2016 Nov; 240(3):282-290. PubMed ID: 27477320
[TBL] [Abstract][Full Text] [Related]
3. BRAF, NRAS and HRAS mutations in spitzoid tumours and their possible pathogenetic significance.
Da Forno PD; Pringle JH; Fletcher A; Bamford M; Su L; Potter L; Saldanha G
Br J Dermatol; 2009 Aug; 161(2):364-72. PubMed ID: 19438459
[TBL] [Abstract][Full Text] [Related]
4. Genetic similarities between Spitz nevus and Spitzoid melanoma in children.
Gill M; Cohen J; Renwick N; Mones JM; Silvers DN; Celebi JT
Cancer; 2004 Dec; 101(11):2636-40. PubMed ID: 15503312
[TBL] [Abstract][Full Text] [Related]
5. Low prevalence of RAS-RAF-activating mutations in Spitz melanocytic nevi compared with other melanocytic lesions.
Indsto JO; Kumar S; Wang L; Crotty KA; Arbuckle SM; Mann GJ
J Cutan Pathol; 2007 Jun; 34(6):448-55. PubMed ID: 17518771
[TBL] [Abstract][Full Text] [Related]
6. Clinical, histopathologic, and genomic features of Spitz tumors with ALK fusions.
Yeh I; de la Fouchardiere A; Pissaloux D; Mully TW; Garrido MC; Vemula SS; Busam KJ; LeBoit PE; McCalmont TH; Bastian BC
Am J Surg Pathol; 2015 May; 39(5):581-91. PubMed ID: 25602801
[TBL] [Abstract][Full Text] [Related]
7. Absence of BRAF gene mutations differentiates spitz nevi from malignant melanoma.
Mihic-Probst D; Perren A; Schmid S; Saremaslani P; Komminoth P; Heitz PU
Anticancer Res; 2004; 24(4):2415-8. PubMed ID: 15330192
[TBL] [Abstract][Full Text] [Related]
8. Genetic alterations in melanocytic tumors.
Takata M; Saida T
J Dermatol Sci; 2006 Jul; 43(1):1-10. PubMed ID: 16750612
[TBL] [Abstract][Full Text] [Related]
9. Genetic and epigenetic alterations in the differential diagnosis of malignant melanoma and spitzoid lesion.
Takata M; Lin J; Takayanagi S; Suzuki T; Ansai S; Kimura T; Cerroni L; Saida T
Br J Dermatol; 2007 Jun; 156(6):1287-94. PubMed ID: 17535228
[TBL] [Abstract][Full Text] [Related]
10. Activating HRAS mutation in agminated Spitz nevi arising in a nevus spilus.
Sarin KY; Sun BK; Bangs CD; Cherry A; Swetter SM; Kim J; Khavari PA
JAMA Dermatol; 2013 Sep; 149(9):1077-81. PubMed ID: 23884457
[TBL] [Abstract][Full Text] [Related]
11. Understanding spitzoid tumours: new insights from molecular pathology.
Da Forno PD; Fletcher A; Pringle JH; Saldanha GS
Br J Dermatol; 2008 Jan; 158(1):4-14. PubMed ID: 17916202
[TBL] [Abstract][Full Text] [Related]
12. Deletion of the ectodomain unleashes the transforming, invasive, and tumorigenic potential of the MET oncogene.
Merlin S; Pietronave S; Locarno D; Valente G; Follenzi A; Prat M
Cancer Sci; 2009 Apr; 100(4):633-8. PubMed ID: 19175607
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic BRAF and the tumor suppressor IGFBP7 in the genesis of atypical spitzoid nevomelanocytic proliferations.
Emley A; Yang S; Wajapeyee N; Green MR; Mahalingam M
J Cutan Pathol; 2010 Mar; 37(3):344-9. PubMed ID: 19788444
[TBL] [Abstract][Full Text] [Related]
14. c-MET kinase inhibitors: a patent review (2011 - 2013).
Zhu K; Kong X; Zhao D; Liang Z; Luo C
Expert Opin Ther Pat; 2014 Feb; 24(2):217-30. PubMed ID: 24266843
[TBL] [Abstract][Full Text] [Related]
15. Only a subset of Met-activated pathways are required to sustain oncogene addiction.
Bertotti A; Burbridge MF; Gastaldi S; Galimi F; Torti D; Medico E; Giordano S; Corso S; Rolland-Valognes G; Lockhart BP; Hickman JA; Comoglio PM; Trusolino L
Sci Signal; 2009 Dec; 2(100):ra80. PubMed ID: 19996456
[TBL] [Abstract][Full Text] [Related]
16. Lack of oncogenic mutations in the c-Met catalytic tyrosine kinase domain in acral lentiginous melanoma.
Seidl H; Weger W; Wolf P; Kerl H; Schaider H
Int J Dermatol; 2008 Dec; 47(12):1327-9. PubMed ID: 19126036
[No Abstract] [Full Text] [Related]
17. [Desmoplastic Spitz nevus: a histopathological review and comparison with desmoplastic melanoma].
Nojavan H; Cribier B; Mehregan DR
Ann Dermatol Venereol; 2009 Oct; 136(10):689-95. PubMed ID: 19801251
[TBL] [Abstract][Full Text] [Related]
18. MET and EGFR mutations identified in ALK-rearranged pulmonary adenocarcinoma: molecular analysis of 25 ALK-positive cases.
Boland JM; Jang JS; Li J; Lee AM; Wampfler JA; Erickson-Johnson MR; Soares I; Yang P; Jen J; Oliveira AM; Yi ES
J Thorac Oncol; 2013 May; 8(5):574-81. PubMed ID: 23449277
[TBL] [Abstract][Full Text] [Related]
19. Copy number variations and clinical outcome in atypical spitz tumors.
Raskin L; Ludgate M; Iyer RK; Ackley TE; Bradford CR; Johnson TM; Fullen DR
Am J Surg Pathol; 2011 Feb; 35(2):243-52. PubMed ID: 21263245
[TBL] [Abstract][Full Text] [Related]
20. Allelic imbalance in the diagnosis of benign, atypical and malignant Spitz tumours.
van Dijk MC; Rombout PD; Mooi WJ; van de Molengraft FJ; van Krieken JH; Ruiter DJ; Ligtenberg MJ
J Pathol; 2002 Jun; 197(2):170-8. PubMed ID: 12015740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
